Cp Gene Ceruloplasmin is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.
The CP (Ceruloplasmin) gene encodes a copper-carrying ferroxidase enzyme that plays essential roles in iron and copper metabolism. Ceruloplasmin converts toxic Fe2+ to Fe3+ for iron loading onto transferrin, and its dysfunction leads to iron accumulation in the brain. Mutations in CP cause aceruloplasminemia, a rare neurodegenerative disorder characterized by iron overload, retinal degeneration, and movement disorders. [1]
This gene is involved in: [2]
Ceruloplasmin (CP) is a gene encoding a major copper-carrying protein in the blood and a key enzyme in iron metabolism. It plays essential roles in copper transport, iron homeostasis, and antioxidant defense, with particular relevance to neurodegenerative diseases. [3]
| Property | Value | [4]
|----------|-------| [5]
| Gene Symbol | CP | [6]
| Chromosomal Location | 3q24 |
| Protein | Ceruloplasmin |
| Function | Copper transport, iron metabolism, ferroxidase activity |
| Related Diseases | Parkinson's Disease, Aceruloplasminemia, Alzheimer's Disease |
Ceruloplasmin is a multi-copper oxidase that:
Ceruloplasmin is a 151 kDa glycoprotein synthesized primarily in the liver as a single polypeptide chain that folds and incorporates 6-8 copper atoms. Key structural features include:
The multi-copper oxidase activity converts Fe²⁺ to Fe³⁺, enabling transferrin binding. This ferroxidase function is essential for:
In the CNS, ceruloplasmin is primarily expressed in:
Astrocytic ceruloplasmin is anchored to the cell surface via GPI and plays a critical role in neuronal iron homeostasis by oxidizing ferrous iron released from neurons for transferrin loading.
The study of Cp Gene Ceruloplasmin has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.
Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.
Ayton S, Lei P. Ceruloplasmin and iron homeostasis in neurodegeneration. J Mol Neurosci. 2014. ↩︎
Tórsdóttir G, Kristinsson J. Copper, ceruloplasmin and oxidative stress in neurodegenerative diseases. Brain Res Bull. 1999. ↩︎
Osaki S, Johnson DA. The ferroxidase activity of ceruloplasmin. J Biol Chem. 1969. ↩︎
Patel BN, David S. A novel GPI-anchored form of ceruloplasmin is expressed by astrocytes. J Biol Chem. 1997. ↩︎
Xin L, Wang J. Ceruloplasmin in neurodegenerative diseases. Metallomics. 2015. ↩︎
Montes S, Rivera-Mancia S. Copper and ceruloplasmin in neurodegenerative diseases. Neurochem Res. 2014. ↩︎